Pasadena, United States
StrokeDx, founded in 2021, is at the forefront of medical innovation, focusing on revolutionizing stroke detection through cutting-edge technology. The company's slogan, "Boldly transforming how stroke is detected with innovative, rapid, and portable devices," encapsulates their commitment to groundbreaking advancements.
Specializing in the integration of AI, Medical Devices, Autonomous and Sensor Tech, and Machine Learning, StrokeDx offers portable, rapid, and non-invasive stroke detection and imaging tools. Their technology is poised to significantly enhance early stroke detection, a critical need that aligns with growing demand for efficient healthcare solutions.
Headquartered in the United States, the company recently secured a $5.00M Seed Round investment on 23 May 2024, with backing from notable investors like DigiTx Partners and Freeflow Ventures. This substantial funding positions StrokeDx for further development and scale-up, attracting additional interest within the healthcare investment community.
